Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Susana M. Campos. (2008) Anti-Epidermal Growth Factor Receptor Strategies for Advanced Breast Cancer. Cancer Investigation 26:8, pages 757-768.
Read now
Read now
Dina Villanueva-García, Karen T. Wang, Heber C. Nielsen & Sujatha M. Ramadurai. (2007) EXPRESSION OF SPECIFIC PROTEIN KINASE C (PKC) ISOFORMS AND LIGAND-SPECIFIC ACTIVATION OF PKCα IN LATE GESTATION FETAL LUNG. Experimental Lung Research 33:3-4, pages 185-196.
Read now
Read now
Azucena Esparís-Ogando, Elena Díaz-Rodríguez, Juan Carlos Montero, Laura Yuste, Piero Crespo & Atanasio Pandiella. (2002) Erk5 Participates in Neuregulin Signal Transduction and Is Constitutively Active in Breast Cancer Cells Overexpressing ErbB2. Molecular and Cellular Biology 22:1, pages 270-285.
Read now
Read now
John C. Wilkinson, Joseph M. Beechem & James V. Staros. (2002) A STOPPED-FLOW FLUORESCENCE ANISOTROPY METHOD FOR MEASURING HORMONE BINDING AND DISSOCIATION KINETICS WITH CELL-SURFACE RECEPTORS IN LIVING CELLS. Journal of Receptors and Signal Transduction 22:1-4, pages 357-371.
Read now
Read now
Claudine S. Bonder, Prue H. Hart, Kate V.L. Davies, Linda C. Buriuy, John J. Finlay-Jones & Joanna M. Woodcock. (2001) Characterization of IL-4 Receptor Components Expressed on Monocytes and Monocyte-derived Macrophages: Variation Associated with Differential Signaling by IL-4. Growth Factors 19:4, pages 207-218.
Read now
Read now
Heidi A. Lane, Iwan Beuvink, Andrea B. Motoyama, John M. Daly, Richard M. Neve & Nancy E. Hynes. (2000) ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency. Molecular and Cellular Biology 20:9, pages 3210-3223.
Read now
Read now
Articles from other publishers (42)
Shuzo Tamura, Yin Wang, Brendan Veeneman, Daniel Hovelson, Armand Bankhead, Luke J. Broses, Guadalupe Lorenzatti Hiles, Monica Liebert, John R. Rubin, Kathleen C. Day, Maha Hussain, Nouri Neamati, Scott Tomlins, Philip L. Palmbos, Petros Grivas & Mark L. Day. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:1, pages 77-90.
Crossref
Crossref
Nadia Sabatini, Enzo Perri & Domenico Rongai. 2018. Food Quality: Balancing Health and Disease. Food Quality: Balancing Health and Disease
145
157
.
Zuquan Zou, Sandrine Bellenger, Karen A. Massey, Anna Nicolaou, Audrey Geissler, Célia Bidu, Bernard Bonnotte, Anne-Sophie Pierre, Mélaine Minville-Walz, Michaël Rialland, John Seubert, Jing X. Kang, Laurent Lagrost, Michel Narce & Jérôme Bellenger. (2013) Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice. Journal of Lipid Research 54:12, pages 3453-3463.
Crossref
Crossref
John F. Kuemmerle, John A. Barnard & Kirk M. McHugh. 2012. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
199
277
.
Thomas Giotis, Haris E. Psillakis, Agapi Panagiotidou, Nikolina Chatzidamianou & Manolis A. Christodoulou. (2011) EGFR Signaling Pathway estimation using a RISE-based asymptotic observer. EGFR Signaling Pathway estimation using a RISE-based asymptotic observer.
Richard W. Cheyne, Laurent Trembleau, Abbie McLaughlin & Tim A.D. Smith. (2011) Changes in 2-fluoro-2-deoxy-d-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab. Nuclear Medicine and Biology 38:3, pages 339-346.
Crossref
Crossref
Myung Sun Lee, Eun Young Cha, Phuong Thien Thuong, Ji Yeon Kim, Moon Sang Ahn & Ji Young Sul. (2010) Down-Regulation of Human Epidermal Growth Factor Receptor 2/neu Oncogene by Corosolic Acid Induces Cell Cycle Arrest and Apoptosis in NCI-N87 Human Gastric Cancer Cells. Biological & Pharmaceutical Bulletin 33:6, pages 931-937.
Crossref
Crossref
Ana Valdehita, Ana M. Bajo, Andrew V. Schally, Jozsef L. Varga, María J. Carmena & Juan C. Prieto. (2009) Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells. Molecular and Cellular Endocrinology 302:1, pages 41-48.
Crossref
Crossref
Hiroshi Nozawa, Gina Howell, Shinsuke Suzuki, Qing Zhang, Yanjun Qi, Judith Klein-Seetharaman, Alan Wells, Jennifer R. Grandis & Sufi M. Thomas. (2008) Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion. Clinical Cancer Research 14:13, pages 4336-4344.
Crossref
Crossref
Yanyan Zhang, Shanggen Zhou, Anne-Sophie Wavreille, James DeWille & Dehua Pei. (2008) Cyclic Peptidyl Inhibitors of Grb2 and Tensin SH2 Domains Identified from Combinatorial Libraries. Journal of Combinatorial Chemistry 10:2, pages 247-255.
Crossref
Crossref
Peter Hammarsten, Stina Häggström Rudolfsson, Roger Henriksson, Pernilla Wikström & Anders Bergh. (2007) Inhibition of the epidermal growth factor receptor enhances castration‐induced prostate involution and reduces testosterone‐stimulated prostate growth in adult rats. The Prostate 67:6, pages 573-581.
Crossref
Crossref
Susana M. Campos. 2007. Breast Cancer: Translational Therapeutic Strategies. Breast Cancer: Translational Therapeutic Strategies
213
234
.
Javier A. Menendez, Adriana Papadimitropoulou, Luciano Vellon & Ruth Lupu. (2006) A genomic explanation connecting “Mediterranean diet”, olive oil and cancer: Oleic acid, the main monounsaturated Fatty acid of olive oil, induces formation of inhibitory “PEA3 transcription factor-PEA3 DNA binding site” complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells. European Journal of Cancer 42:15, pages 2425-2432.
Crossref
Crossref
Jyoti Nautiyal. (2006) Emerging therapies in gastrointestinal cancers. World Journal of Gastroenterology 12:46, pages 7440.
Crossref
Crossref
John A. Barnard & Kirk M. McHugh. 2006. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract
183
246
.
Ramón Colomer & Javier A. Menéndez. (2006) Mediterranean diet, olive oil and cancer. Clinical and Translational Oncology 8:1, pages 15-21.
Crossref
Crossref
Eric K. Rowinsky. 2006. Breast Cancer and Molecular Medicine. Breast Cancer and Molecular Medicine
741
780
.
Thomas Friess, Werner Scheuer & Max Hasmann. (2005) Combination Treatment with Erlotinib and Pertuzumab against Human Tumor Xenografts Is Superior to Monotherapy. Clinical Cancer Research 11:14, pages 5300-5309.
Crossref
Crossref
Patricia Formento, Jean-Michel Hannoun-Levi, Françoise Gérard, Christiane Mazeau, Jean-Louis Fischel, M.C. Etienne-Grimaldi, Jean Gugenheim & Gérard Milano. (2005) Gefitinib–trastuzumab combination on hormone-refractory prostate cancer xenograft. European Journal of Cancer 41:10, pages 1467-1473.
Crossref
Crossref
James G. Christensen, Patrick W. Vincent, Wayne D. Klohs, David W. Fry, Wilbur R. Leopold & William L. Elliott. (2005) Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Molecular Cancer Therapeutics 4:6, pages 938-947.
Crossref
Crossref
J.A. Menendez, L. Vellon, R. Colomer & R. Lupu. (2005) Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification. Annals of Oncology 16:3, pages 359-371.
Crossref
Crossref
Patricia Formento, Jean-Michel Hannoun-Levi, Jean-Louis Fischel, Nicolas Magné, Marie-Christine Etienne-Grimaldi & Gérard Milano. (2004) Dual HER 1-2 targeting of hormone-refractory prostate cancer by ZD1839 and trastuzumab. European Journal of Cancer 40:18, pages 2837-2844.
Crossref
Crossref
Stephanie C. Pero, Girja S. Shukla, Amy L. Armstrong, Daniel Peterson, Susan P. Fuller, Katherine Godin, Sarah L. Kingsley-Richards, Donald L. Weaver, Jeffrey Bond & David N. Krag. (2004) Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells. International Journal of Cancer 111:6, pages 951-960.
Crossref
Crossref
Seiji Sumigama, Tomomi Ito, Hiroaki Kajiyama, Kiyosumi Shibata, Koji Tamakoshi, Fumitaka Kikkawa, Trevor Williams, Michael A Tainsky, Seiji Nomura & Shigehiko Mizutani. (2004) Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2α. Oncogene 23:32, pages 5496-5504.
Crossref
Crossref
David R. Gandara, Howard West, Kari Chansky, Angela M. Davies, Derick H. M. Lau, John Crowley, Paul H. Gumerlock, Fred R. Hirsch & Wilbur A. Franklin. (2004) Bronchioloalveolar Carcinoma. Clinical Cancer Research 10:12, pages 4205s-4209s.
Crossref
Crossref
Yun Zhu & Frank E. Jones. (2004) The ErbB signaling network is coordinately expressed and activated in the mouse prostate. The Prostate 60:1, pages 68-75.
Crossref
Crossref
Eric K. Rowinsky. (2004) The erbB Family: Targets for Therapeutic Development Against Cancer and Therapeutic Strategies Using Monoclonal Antibodies and Tyrosine Kinase Inhibitors. Annual Review of Medicine 55:1, pages 433-457.
Crossref
Crossref
Eric K. Rowinsky. (2003) Signal Events: Cell Signal Transduction and Its Inhibition in Cancer. The Oncologist 8:S3, pages 5-17.
Crossref
Crossref
Iain R. Hutcheson, Janice M. Knowlden, Tracie-Ann Madden, Denise Barrow, Julia M.W. Gee, Alan E. Wakeling & Robert I. Nicholson. (2003) Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells. Breast Cancer Research and Treatment 81:1, pages 81-93.
Crossref
Crossref
Federico CappuzzoVanesa GregorcElisa RossiAlessandra CancellieriElisabetta MagriniCarlo Terenzio PatiesGiovanni CeresoliLaura LombardoStefania BartoliniCesare CalandriMarisa De RosaEugenio VillaLucio Crinò. (2003) Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC. Journal of Clinical Oncology 21:14, pages 2658-2663.
Crossref
Crossref
Gerald E Stoica, Thomas F Franke, Anton Wellstein, Elisha Morgan, Frank Czubayko, Heinz-Joachim List, Ronald Reiter, Mary Beth Martin & Adriana Stoica. (2003) Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway. Oncogene 22:14, pages 2073-2087.
Crossref
Crossref
Christopher J. Ormandy, Elizabeth A. Musgrove, Rina Hui, Roger J. Daly & Robert L. Sutherland. (2003) Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer. Breast Cancer Research and Treatment 78:3, pages 323-335.
Crossref
Crossref
Janice M. Knowlden, Iain R. Hutcheson, Helen E. Jones, Tracieann Madden, Julia M. W. Gee, Maureen E. Harper, Denise Barrow, Alan E. Wakeling & Robert I. Nicholson. (2003) Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells. Endocrinology 144:3, pages 1032-1044.
Crossref
Crossref
Filomena O Dimayuga, Qunxing Ding, Jeffrey N Keller, Mark A Marchionni, Kim B Seroogy & Annadora J Bruce-Keller. (2003) The neuregulin GGF2 attenuates free radical release from activated microglial cells. Journal of Neuroimmunology 136:1-2, pages 67-74.
Crossref
Crossref
Jonathan A. Ewald, John C. Wilkinson, Cheryl A. Guyer & James V. Staros. (2003) Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells. Experimental Cell Research 282:2, pages 121-131.
Crossref
Crossref
Robert N. Jorissen, Francesca Walker, Normand Pouliot, Thomas P.J. Garrett, Colin W. Ward & Antony W. Burgess. 2003. The EGF Receptor Family. The EGF Receptor Family
33
55
.
Wenle Xia, Robert J Mullin, Barry R Keith, Lei-Hua Liu, Hong Ma, David W Rusnak, Gary Owens, Krystal J Alligood & Neil L Spector. (2002) Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene 21:41, pages 6255-6263.
Crossref
Crossref
W. Zhou & G. Carpenter. (2002) ErbB-4: a receptor tyrosine kinase. Inflammation Research 51:2, pages 91-101.
Crossref
Crossref
William A Denny. 2002. Anticancer Drug Development. Anticancer Drug Development
187
202
.
W.R. Leopold, Alex Bridges, Stuart Decker, David W. Fry, Alan Kraker & Judith Sebolt-Leopold. 2002. Anticancer Drug Development. Anticancer Drug Development
31
53
.
Jonathan A. Ewald, Kenneth J. Coker, James O. Price, James V. Staros & Cheryl A. Guyer. (2001) Stimulation of Mitogenic Pathways through Kinase-Impaired Mutants of the Epidermal Growth Factor Receptor. Experimental Cell Research 268:2, pages 262-273.
Crossref
Crossref
Rania Kairouz & Roger J Daly. (2000) Tyrosine kinase signalling in breast cancer: Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates. Breast Cancer Research 2:3.
Crossref
Crossref